Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-16/18”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Not applicableUnknownNCT03206138
What this trial is testing

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Seoul St. Mary's Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303751
What this trial is testing

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Who this might be right for
HPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections
Institut d'Investigació Biomèdica de Bellvitge 80
Large-scale testing (Phase 3)Study completedNCT00337818
What this trial is testing

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Who this might be right for
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
GlaxoSmithKline 770
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Testing effectiveness (Phase 2)Study completedNCT00263744
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Who this might be right for
Healthy
MedImmune LLC 60
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Large-scale testing (Phase 3)Study completedNCT00196924
What this trial is testing

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2,067
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Large-scale testing (Phase 3)Study completedNCT01627561
What this trial is testing

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Testing effectiveness (Phase 2)Study completedNCT03444376
What this trial is testing

The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Genexine, Inc. 65
Not applicableStudy completedNCT04000503
What this trial is testing

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

Who this might be right for
Human Papillomavirus 16Human Papillomavirus 18Papillomavirus Infections+2 more
University of British Columbia 2,019
Not applicableStudy completedNCT01520272
What this trial is testing

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

Who this might be right for
HPV16 Anitbody Levels Post VaccinationHPV18 Antibody Levels Post Vaccination
National Cancer Institute (NCI) 376
Post-approval studies (Phase 4)Active Not RecruitingNCT07314307
What this trial is testing

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Who this might be right for
Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Karolinska Institutet 150,000
Large-scale testing (Phase 3)Study completedNCT00250276
What this trial is testing

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 798
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Next Page